Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
No Borrowings in the last few periods;
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
No Fixed Assets in the last few periods;
Investments
YoY Growth in year ended Mar 2025 is -100.00% vs 0.00% in Mar 2024
Current Assets
YoY Growth in year ended Mar 2025 is -9.97% vs 12.79% in Mar 2024
Compare Balance Sheet Results of Genomic Valley
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
3.05
4.00
-0.95
-23.75%
Share Warrants & Outstandings
Total Reserve
0.84
0.02
0.82
4,100.00%
Shareholder's Funds
3.90
4.02
-0.12
-2.99%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
0.18
-0.18
-100.00%
Secured Loans
0.00
0.00
0.00
0.00%
Unsecured Loans
0.00
0.18
-0.18
-100.00%
Deferred Tax Assets / Liabilities
0.00
-0.00
0.00
0.00%
Other Long Term Liabilities
0.00
0.00
0.00
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.00
0.00
0.00%
Total Non-Current Liabilities
0.00
0.77
-0.77
-100.00%
Current Liabilities
Trade Payables
0.01
3.22
-3.21
-99.69%
Other Current Liabilities
0.36
0.54
-0.18
-33.33%
Short Term Borrowings
0.00
5.32
-5.32
-100.00%
Short Term Provisions
0.09
0.04
0.05
125.00%
Total Current Liabilities
0.46
9.12
-8.66
-94.96%
Total Liabilities
4.36
13.91
-9.55
-68.66%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
0.01
0.07
-0.06
-85.71%
Less: Accumulated Depreciation
0.00
0.05
-0.05
-100.00%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
0.01
0.02
-0.01
-50.00%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
1.91
-1.91
-100.00%
Long Term Loans & Advances
1.73
0.59
1.14
193.22%
Other Non Current Assets
0.00
0.00
0.00
0.00%
Total Non-Current Assets
1.73
2.53
-0.80
-31.62%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
0.28
1.84
-1.56
-84.78%
Sundry Debtors
2.21
7.39
-5.18
-70.09%
Cash and Bank
0.05
0.05
0.00
0.00%
Other Current Assets
0.00
0.03
-0.03
-100.00%
Short Term Loans and Advances
0.08
2.08
-2.00
-96.15%
Total Current Assets
2.62
11.38
-8.76
-76.98%
Net Current Assets (Including Current Investments)
2.16
2.27
-0.11
-4.85%
Total Current Assets Excluding Current Investments
2.62
11.38
-8.76
-76.98%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
4.36
13.91
-9.55
-68.66%
Contingent Liabilities
0.00
0.00
0.00
0.00%
Total Debt
0.00
6.09
-6.09
-100.00%
Book Value per share (adjusted)
12.76
1.01
11.75
1,163.37%
Annual - Borrowings
Borrowings 0.00 Cr
in Mar 2025Figures in Cr
No Borrowings in the last few periods;
Annual - Other Long Term Liabilities
Other Long Term Liabilities 0.00 Cr
in Mar 2025Figures in Cr
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 0.01 Cr
in Mar 2025Figures in Cr
No Fixed Assets in the last few periods;
Annual - Investments
Investments 0.00 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -100.00% vs 0.00% in Mar 2024
Annual - Current Assets
Current Assets 2.62 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -9.97% vs 12.79% in Mar 2024






